Description of 3 patients with myasthenia gravis and COVID-19

BACKGROUND: The COVID-19 pandemic presents two main concerns for patients with myasthenia gravis (MG); chronic immunosuppression may put them at greater risk, and some proposed treatments for COVID-19 could cause MG exacerbation. CASE DESCRIPTION: We present three patients with generalized seroposit...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Neurol Sci
Autors principals: Rein, Netaniel, Haham, Nitzan, Orenbuch-Harroch, Efrat, Romain, Marc, Argov, Zohar, Vaknin-Dembinsky, Adi, Gotkine, Marc
Format: Artigo
Idioma:Inglês
Publicat: Elsevier B.V. 2020
Matèries:
Clinical Short Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7832365/
https://ncbi.nlm.nih.gov/pubmed/32731059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jns.2020.117053
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars